Uptake and Acceptability of Home-use of Mifepristone for Medical Abortion

Uptake and Acceptability of Home-use of Mifepristone for Medical Abortion

The primary aim of this study is to assess the acceptability of home-use mifepristone for termination of pregnancy among women who choose it and their providers. The investigators' secondary aims are to assess rates of follow-up, adherence, efficacy, complications, lost productivity, and to estimate the minimum proportion of women who choose home-use over clinic use of mifepristone.

Inclusion Criteria:

• Reproductive age women seeking abortion services.
• Eligible women will be in general good health and assessed by a clinician to have an intrauterine pregnancy less than 64 days L.M.P on the day mifepristone will be taken.
• Participants must be eligible for medical abortion according to clinician and clinic standards.
• In the United States, women only 18 years and older will be eligible to participate, unless the study site obtains a waiver to include minors.